1 results match your criteria: "University of Florida at Jacksonville School of Medicine[Affiliation]"
Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease.
J Perinatol
January 2022
Department of Medicine, University of Florida at Jacksonville School of Medicine, Jacksonville, FL, USA.
Objective: To evaluate the efficacy and safety of tin mesoporphyrin (SnMP) in neonates with hyperbilirubinemia (HB) due to hemolysis.
Study Design: This multicenter, placebo-controlled phase 2b study (NCT01887327) randomized newborns (35-42 weeks) with hemolysis started on phototherapy (PT) to placebo (Ctrl), SnMP 3.0 mg/kg, or SnMP 4.